AVR-RD-02

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	1

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04145037 (ClinicalTrials.gov)	May 30, 2019	27/8/2019	Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02for Subjects With Type 1 Gaucher Disea ...	The Guard1 Trial, an Open-Label, Multinational Phase 1/2 Study of the Safety and Efficacy of Ex Vivo ...	Gaucher Disease	Drug: AVR-RD-02	AVROBIO	NULL	Recruiting	18 Years	50 Years	All	16	Phase 1/Phase 2	United States;Australia;Canada

First Previous1Next Last